Drug profile · INN
vimseltinib
ROMVIMZA
vimseltinib (ROMVIMZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Drug details — vimseltinib
- US status
- approved
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
vimseltinib (ROMVIMZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is vimseltinib?
vimseltinib (ROMVIMZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for vimseltinib?
ROMVIMZA is a marketed brand name for vimseltinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of vimseltinib?
vimseltinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.